U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07785102) titled 'Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101' on Aug. 18.
Brief Summary: In this pilot study, investigators aim to combine D-cycloserine, lurasidone, and single-day repeated intermittent Theta Burst Stimulation (iTBS) to preliminarily assess clinical improvement in an open-label cohort and monitor for adverse events over a 6-week follow-up period.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Major Depression
Intervention:
DEVICE: TMS
Transcranial Magnetic Stimulation (TMS): TMS involves a procedure where a coil is placed on the scalp and magnetic energy enters the participant's brain i...